International Clinical Trial: Bifidobacterium Quadruple Viable Tablets in Preventing Symptom Relapse after Colonoscopy in Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115212) titled 'Bifidobacterium Quadruple Viable Tablets in Preventing Symptom Relapse after Colonoscopy in Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial' on Dec. 23, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Condition: Diarrhea-predominant irritable bowel syndrome

Intervention: Probiotic Intervention Group:Bifidobacterium Quadruple Viable Tablets.? Administration: Orally, three times daily, three tablets each time, for 4 cons...